Efirenz limits HIV infection by: (A) Binding to active site of HIV reverse transcriptase, (B) Impairing the binding of HIV virion to CD4 receptor on T tubes, (C) Inhibiting the HIV protease, (D) Serving as an allosteric inhibitor of HIV reverse transcriptase
Answer is D. Ref-KDT 6/e 772 Allosteric inhibitor Mein snong nucleoside reverse transcriptase inhibitors